Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0010 Transporter Info
Gene Name	SLC22A1
Transporter Name	Organic cation transporter 1
Gene ID	6580
UniProt ID	O15245

Post-Translational Modification of This DT
Overview of SLC22A1 Modification Sites with Functional and Structural Information
Sequence	M P T V D D I L E Q V G E S G W F Q K Q A F L I L C L L S A A F A P I C V G I V F L G F T P D H H C Q S P G V A E L S Q R C G W S P A E E L N Y T V P G L G P A G E A F L G Q C R R Y E V D W N Q S A L S C V D P L A S L A T N R S H L P L G P C Q D G W V Y D T P G S S I V T E F N L V C A D S W K L D L F Q S C L N A G F L F G S L G V G Y F A D R F G R K L C L L G T V L V N A V S G V L M A F S P N Y M S M L L F R L L Q G L V S K G N W M A G Y T L I T E F V G S G S R R T V A I M Y Q M A F T V G L V A L T G L A Y A L P H W R W L Q L A V S L P T F L F L L Y Y W C V P E S P R W L L S Q K R N T E A I K I M D H I A Q K N G K L P P A D L K M L S L E E D V T E K L S P S F A D L F R T P R L R K R T F I L M Y L W F T D S V L Y Q G L I L H M G A T S G N L Y L D F L Y S A L V E I P G A F I A L I T I D R V G R I Y P M A M S N L L A G A A C L V M I F I S P D L H W L N I I I M C V G R M G I T I A I Q M I C L V N A E L Y P T F V R N L G V M V C S S L C D I G G I I T P F I V F R L R E V W Q A L P L I L F A V L G L L A A G V T L L L P E T K G V A L P E T M K D A E N L G R K A K P K E N T I Y L K V Q T S E P S G T
PTM type	X-N-glycosylation X-Phosphorylation X: Amino Acid

N-glycosylation
Asparagine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC22A1			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	71
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC22A1 Asparagine 71 has the potential to affect its expression or activity.
Phosphorylation
Serine	7 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC22A1			[2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	213
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC22A1 Serine 213 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC22A1			[3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	230
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC22A1 Serine 230 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC22A1			[3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	232
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC22A1 Serine 232 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC22A1			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	331
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC22A1 Serine 331 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC22A1			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	333
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC22A1 Serine 333 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC22A1			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	549
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC22A1 Serine 549 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC22A1			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	552
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC22A1 Serine 552 has the potential to affect its expression or activity.
Threonine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC22A1			[3]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	222
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC22A1 Threonine 222 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC22A1			[3]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	225
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC22A1 Threonine 225 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC22A1			[6]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	510
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC22A1 Threonine 510 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC22A1			[5] , [7]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	541
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC22A1 Threonine 541 has the potential to affect its expression or activity.
Tyrosine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Potentially affecting the transporter			[8] , [9]
Role of PTM	On/Off Switch
Modified Residue	Tyrosine
Modified State	Tyrosine kinase inhibitors (Pazopanib)
Experimental Method	Co-Immunoprecipitation
Detailed Description	Removal of the Phosphorylation at SLC22A1 Tyrosine (i.e. Tyrosine kinase inhibitors (Pazopanib)) have been reported to have the potential to affect the transporter.
PTM Phenomenon 2	Have the potential to influence SLC22A1			[3]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	221
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC22A1 Tyrosine 221 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC22A1			[5]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	543
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC22A1 Tyrosine 543 has the potential to affect its expression or activity.

References
1	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: S22A1_HUMAN)
2	An integrated strategy for highly sensitive phosphoproteome analysis from low micrograms of protein samples. Analyst. 2018 Jul 23;143(15):3693-3701.
3	Citric acid-assisted two-step enrichment with TiO2 enhances the separation of multi- and monophosphorylated peptides and increases phosphoprotein profiling. J Proteome Res. 2013 Jun 7;12(6):2467-76.
4	Phosphoproteome Analysis Reveals Differential Mode of Action of Sorafenib in Wildtype and Mutated FLT3 Acute Myeloid Leukemia (AML) Cells. Mol Cell Proteomics. 2017 Jul;16(7):1365-1376.
5	FAIMS and Phosphoproteomics of Fibroblast Growth Factor Signaling: Enhanced Identification of Multiply Phosphorylated Peptides. J Proteome Res. 2015 Dec 4;14(12):5077-87.
6	iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
7	UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515.
8	Inhibition of OCT2, MATE1 and MATE2-K as a possible mechanism of drug interaction between pazopanib and cisplatin. Pharmacol Res. 2016 Aug;110:89-95.
9	A phosphotyrosine switch regulates organic cation transporters. Nat Commun. 2016 Mar 16;7:10880.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence